MedMesh.i
Curation
PubMed
Racine
Curation
Checkpoint
PubMed
Racine
PubMed
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration) - Curation (PubMed)

Index « MedMesh.i » - entrée « Cost-Benefit Analysis »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Cost of Illness < Cost-Benefit Analysis < Costs and Cost Analysis  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000219 (2016) Clément François [États-Unis] ; Robert A. Hauser [États-Unis] ; Samuel Aballéa [France] ; Julie Dorey [États-Unis] ; Elizaveta Kharitonova [France] ; L Arthur Hewitt [États-Unis]Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial data.
000392 (2015) Nathan R. Riding [Royaume-Uni] ; Sanjay Sharma [Royaume-Uni] ; Othman Salah [Qatar] ; Nelly Khalil [Qatar] ; François Carré [France] ; Keith P. George [Royaume-Uni] ; Bruce Hamilton [Nouvelle-Zélande] ; Hakim Chalabi [Qatar] ; Gregory P. Whyte [Royaume-Uni] ; Mathew G. Wilson [Oman]Systematic echocardiography is not efficacious when screening an ethnically diverse cohort of athletes in West Asia.
000E22 (2006) B. Brembilla-Perrot [France][Respective interest of two techniques of electrophysiological study in patient without heart disease].
000E37 (2006) Joumana Hudry [France] ; Juha O. Rinne ; Tapani Ker Nen ; Laurent Eckert ; John M. CochranCost-utility model of rasagiline in the treatment of advanced Parkinson's disease in Finland.
000E40 (2006) V. Fraix [France] ; J-L Houeto ; C. Lagrange ; C. Le Pen ; P. Krystkowiak ; D. Guehl ; C. Ardouin ; M-L Welter ; F. Maurel ; L. Defebvre ; A. Rougier ; A-L Benabid ; V. Mesnage ; M. Ligier ; S. Blond ; P. Burbaud ; B. Bioulac ; A. Destée ; P. Cornu ; P. PollakClinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease.
001068 (2003) Christine Brefel-Courbon [France] ; Karine Desboeuf ; Claire Thalamas ; Monique Galitzky ; Jean-Michel Senard ; Olivier Rascol ; Jean-Louis MontastrucClinical and economic analysis of spa therapy in Parkinson's disease.
001088 (2003) Olivier Rascol [France] ; C. Brefel-Courbon ; P. Payoux ; J. FerreiraThe management of patients with early Parkinson's disease.
001134 (2002) Selegiline: a second look. Six years later: too risky in Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i -k "Cost-Benefit Analysis" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i  \
                -Sk "Cost-Benefit Analysis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Cost-Benefit Analysis
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024